347 related articles for article (PubMed ID: 23242970)
1. Development of a new bioprocess scheme using frozen seed train intermediates to initiate CHO cell culture manufacturing campaigns.
Seth G; Hamilton RW; Stapp TR; Zheng L; Meier A; Petty K; Leung S; Chary S
Biotechnol Bioeng; 2013 May; 110(5):1376-85. PubMed ID: 23242970
[TBL] [Abstract][Full Text] [Related]
2. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
3. Optimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors.
Pohlscheidt M; Jacobs M; Wolf S; Thiele J; Jockwer A; Gabelsberger J; Jenzsch M; Tebbe H; Burg J
Biotechnol Prog; 2013; 29(1):222-9. PubMed ID: 23225663
[TBL] [Abstract][Full Text] [Related]
4. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
5. Optimal conditions for freezing CHO-S and HEK293-EBNA cell lines: influence of Me2SO, freeze density, and PEI-mediated transfection on revitalization and growth of cells, and expression of recombinant protein.
Kleman MI; Oellers K; Lullau E
Biotechnol Bioeng; 2008 Aug; 100(5):911-22. PubMed ID: 18351658
[TBL] [Abstract][Full Text] [Related]
6. [Development and application of perfusion culture producing seed cells in WAVE bioreactor].
Yang J; Sui L
Sheng Wu Gong Cheng Xue Bao; 2012 Mar; 28(3):358-67. PubMed ID: 22712394
[TBL] [Abstract][Full Text] [Related]
7. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
[TBL] [Abstract][Full Text] [Related]
8. Defining process design space for monoclonal antibody cell culture.
Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
[TBL] [Abstract][Full Text] [Related]
9. Case Study: an accelerated 8-day monoclonal antibody production process based on high seeding densities.
Padawer I; Ling WL; Bai Y
Biotechnol Prog; 2013; 29(3):829-32. PubMed ID: 23596148
[TBL] [Abstract][Full Text] [Related]
10. Development of a scale down cell culture model using multivariate analysis as a qualification tool.
Tsang VL; Wang AX; Yusuf-Makagiansar H; Ryll T
Biotechnol Prog; 2014; 30(1):152-60. PubMed ID: 24124180
[TBL] [Abstract][Full Text] [Related]
11. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study.
Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D
Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of cell culture bioprocess data--lactate consumption as process indicator.
Le H; Kabbur S; Pollastrini L; Sun Z; Mills K; Johnson K; Karypis G; Hu WS
J Biotechnol; 2012 Dec; 162(2-3):210-23. PubMed ID: 22974585
[TBL] [Abstract][Full Text] [Related]
13. A new large-scale manufacturing platform for complex biopharmaceuticals.
Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
[TBL] [Abstract][Full Text] [Related]
14. Synchronous fluorescence spectroscopy as a novel tool to enable PAT applications in bioprocesses.
Teixeira AP; Duarte TM; Carrondo MJ; Alves PM
Biotechnol Bioeng; 2011 Aug; 108(8):1852-61. PubMed ID: 21391211
[TBL] [Abstract][Full Text] [Related]
15. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.
Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST
Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562
[TBL] [Abstract][Full Text] [Related]
16. Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE Bioreactor™-part II: Applications for antibody production and cryopreservation.
Clincke MF; Mölleryd C; Samani PK; Lindskog E; Fäldt E; Walsh K; Chotteau V
Biotechnol Prog; 2013; 29(3):768-77. PubMed ID: 23436783
[TBL] [Abstract][Full Text] [Related]
17. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
[TBL] [Abstract][Full Text] [Related]
18. Scale-up analysis for a CHO cell culture process in large-scale bioreactors.
Xing Z; Kenty BM; Li ZJ; Lee SS
Biotechnol Bioeng; 2009 Jul; 103(4):733-46. PubMed ID: 19280669
[TBL] [Abstract][Full Text] [Related]
19. Batch, fed-batch, and microcarrier cultures with CHO cell lines in a pressure-cycle driven miniaturized bioreactor.
Kim BJ; Zhao T; Young L; Zhou P; Shuler ML
Biotechnol Bioeng; 2012 Jan; 109(1):137-45. PubMed ID: 21965160
[TBL] [Abstract][Full Text] [Related]
20. Bench-Scale Stirred-Tank Bioreactor for Recombinant Protein Production in Chinese Hamster Ovary (CHO) Cells in Suspension.
Monteil DT; Kuan J
Methods Mol Biol; 2018; 1850():133-145. PubMed ID: 30242685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
